Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Bure Equity AB ( (SE:BURE) ) has shared an update.
Bure Equity AB, a Swedish investment company, reported a challenging financial performance for the first nine months of 2025, with a 17.5% decrease in net asset value per share and a total return on shares of -26.7%. Despite some stabilization in the third quarter, the company faced currency struggles and lower growth, impacting its portfolio companies. Key activities included the acquisition of a stake in Silex Microsystems and divestments in Mycronic and Ovzon. The CEO noted both positive developments in companies like Vitrolife and challenges such as Yubico’s unmet expectations.
The most recent analyst rating on (SE:BURE) stock is a Hold with a SEK296.00 price target. To see the full list of analyst forecasts on Bure Equity AB stock, see the SE:BURE Stock Forecast page.
More about Bure Equity AB
Average Trading Volume: 55,847
Technical Sentiment Signal: Hold
Current Market Cap: SEK19.86B
See more data about BURE stock on TipRanks’ Stock Analysis page.